交易 Sanofi SA - SAN CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | 0.33 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.024161% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | -0.020283% | ||||||||
隔夜费时间 | 22:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | EUR | ||||||||
保证金 | 20% | ||||||||
上市交易所 | France | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Sanofi SA ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Feb 6, 2023 | 84.60 | 0.47 | 0.56% | 84.13 | 85.16 | 83.75 |
Feb 3, 2023 | 84.69 | 1.58 | 1.90% | 83.11 | 86.16 | 82.05 |
Feb 2, 2023 | 86.81 | -1.03 | -1.17% | 87.84 | 88.57 | 86.32 |
Feb 1, 2023 | 88.64 | -1.25 | -1.39% | 89.89 | 89.89 | 88.24 |
Jan 31, 2023 | 89.81 | 0.07 | 0.08% | 89.74 | 90.46 | 88.84 |
Jan 30, 2023 | 89.75 | 0.58 | 0.65% | 89.17 | 90.07 | 88.72 |
Jan 27, 2023 | 89.44 | 0.54 | 0.61% | 88.90 | 89.69 | 88.90 |
Jan 26, 2023 | 89.69 | -0.57 | -0.63% | 90.26 | 90.92 | 89.57 |
Jan 25, 2023 | 89.82 | 0.48 | 0.54% | 89.34 | 89.84 | 88.92 |
Jan 24, 2023 | 89.12 | -0.67 | -0.75% | 89.79 | 89.86 | 88.74 |
Jan 23, 2023 | 89.66 | -0.21 | -0.23% | 89.87 | 90.00 | 89.24 |
Jan 20, 2023 | 90.51 | -0.31 | -0.34% | 90.82 | 91.31 | 90.30 |
Jan 19, 2023 | 91.25 | -0.06 | -0.07% | 91.31 | 91.89 | 90.29 |
Jan 18, 2023 | 91.05 | -0.08 | -0.09% | 91.13 | 91.54 | 90.69 |
Jan 17, 2023 | 91.75 | 0.25 | 0.27% | 91.50 | 91.93 | 91.23 |
Jan 16, 2023 | 91.62 | 0.25 | 0.27% | 91.37 | 91.73 | 90.88 |
Jan 13, 2023 | 91.07 | 0.20 | 0.22% | 90.87 | 91.55 | 90.33 |
Jan 12, 2023 | 90.27 | 0.01 | 0.01% | 90.26 | 91.13 | 89.01 |
Jan 11, 2023 | 89.92 | -0.44 | -0.49% | 90.36 | 90.65 | 89.74 |
Jan 10, 2023 | 89.94 | 0.21 | 0.23% | 89.73 | 91.15 | 89.63 |
Sanofi SA Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
总收入 | 34696 | 36221 | 35677 | 37631 | 37369 | 39175 |
收入 | 34696 | 36221 | 35677 | 37631 | 37369 | 39175 |
收入成本,共计 | 10701 | 11613 | 11435 | 11979 | 12159 | 12255 |
毛利 | 23995 | 24608 | 24242 | 25652 | 25210 | 26920 |
总营业费用 | 28165 | 30417 | 31001 | 34580 | 23256 | 31049 |
销售/一般/行政费用,总计 | 9422 | 10072 | 9772 | 9777 | 9304 | 9457 |
研究与开发 | 5156 | 5472 | 5890 | 6017 | 5528 | 5689 |
Depreciation / Amortization | 1769 | 1866 | 2264 | 2262 | 1774 | 1681 |
异常费用(收入) | 860 | 1239 | 1696 | 3966 | 777 | 235 |
Other Operating Expenses, Total | 257 | 155 | -56 | 579 | 1096 | 1732 |
营业收入 | 6531 | 5804 | 4676 | 3051 | 14113 | 8126 |
利息收入(费用),非经营净值 | -237 | -221 | -273 | -210 | -263 | -289 |
其他,净值 | -619 | -52 | 2 | -89 | -72 | -39 |
税前净收入 | 5675 | 5531 | 4405 | 2752 | 13778 | 7798 |
税后净收入 | 4350 | 3809 | 3924 | 2631 | 11971 | 6240 |
少数股东权益 | -91 | -121 | -104 | -31 | -36 | -56 |
Equity In Affiliates | 136 | 85 | 499 | 255 | 359 | 39 |
未计算非常项目前的净收益 | 4395 | 3773 | 4319 | 2855 | 12294 | 6223 |
非常规项目总计 | 314 | 4643 | -13 | -101 | 0 | 0 |
净收入 | 4709 | 8416 | 4306 | 2754 | 12294 | 6223 |
普通股股东可获收益 (不含非经常性项目) | 4395 | 3773 | 4319 | 2855 | 12294 | 6223 |
普通股股东可获收益 (含非經常性項目) | 4709 | 8416 | 4306 | 2754 | 12294 | 6223 |
摊薄调整 | -4.52 | -4.448 | ||||
摊薄净收入 | 4704.48 | 8411.55 | 4306 | 2754 | 12294 | 6223 |
摊薄后加权平均股 | 1296 | 1266.8 | 1255.2 | 1257.1 | 1260.1 | 1257.9 |
扣除特别项目的每股摊薄盈利 | 3.38772 | 2.97486 | 3.44089 | 2.2711 | 9.75637 | 4.94713 |
Dividends per Share - Common Stock Primary Issue | 2.96 | 3.03 | 3.07 | 3.15 | 3.2 | 3.31263 |
每股正常摊薄盈利 | 3.89636 | 3.64841 | 4.64452 | 5.28727 | 10.2921 | 5.09663 |
利息费用(收入) - 净运营 | 0 | -7382 | 0 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
总收入 | 8886 | 17931 | 10829 | 21244 | 10053 |
收入 | 8886 | 17931 | 10829 | 21244 | 10053 |
收入成本,共计 | 2684 | 5541 | 3238 | 6714 | 2880 |
毛利 | 6202 | 12390 | 7591 | 14530 | 7173 |
总营业费用 | 6828 | 14318 | 7787 | 16731 | 7656 |
销售/一般/行政费用,总计 | 2194 | 4530 | 2267 | 5025 | 2379 |
研究与开发 | 1266 | 2663 | 1443 | 3029 | 1489 |
Depreciation / Amortization | 389 | 775 | 385 | 805 | 449 |
异常费用(收入) | 158 | 505 | 170 | 512 | 198 |
Other Operating Expenses, Total | 137 | 304 | 284 | 646 | 261 |
营业收入 | 2058 | 3613 | 3042 | 4513 | 2397 |
利息收入(费用),非经营净值 | -85 | -155 | -85 | -153 | -78 |
税前净收入 | 1973 | 3452 | 2957 | 4346 | 2319 |
税后净收入 | 1569 | 2770 | 2348 | 3470 | 1987 |
少数股东权益 | -12 | -20 | -26 | -36 | -8 |
Equity In Affiliates | 9 | 26 | -5 | 13 | 30 |
未计算非常项目前的净收益 | 1566 | 2776 | 2317 | 3447 | 2009 |
净收入 | 1566 | 2776 | 2317 | 3447 | 2009 |
普通股股东可获收益 (不含非经常性项目) | 1566 | 2776 | 2317 | 3447 | 2009 |
普通股股东可获收益 (含非經常性項目) | 1566 | 2776 | 2317 | 3447 | 2009 |
摊薄净收入 | 1566 | 2776 | 2317 | 3447 | 2009 |
摊薄后加权平均股 | 1249.3 | 1255.6 | 1254.5 | 1260.2 | 1249.2 |
扣除特别项目的每股摊薄盈利 | 1.2535 | 2.2109 | 1.84695 | 2.73528 | 1.60823 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 3.31263 | 0 |
每股正常摊薄盈利 | 1.35408 | 2.53363 | 1.95455 | 3.05967 | 1.74404 |
利息费用(收入) - 净运营 | 0 | 0 | 0 | ||
其他,净值 | -6 | -14 | |||
非常规项目总计 | 0 |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
流动资产总额 | 26691 | 26354 | 24579 | 28611 | 33703 | 30564 |
现金和短期投资 | 10304 | 10315 | 7124 | 9853 | 14815 | 11152 |
Cash | 1077 | 661 | 701 | 1144 | 1358 | |
现金等价物 | 9196 | 10315 | 6264 | 8726 | 12771 | 8740 |
短期投资 | 31 | 199 | 426 | 900 | 1054 | |
应收账款总额,净额 | 9050 | 7216 | 9345 | 10083 | 9953 | 9787 |
Accounts Receivable - Trade, Net | 7311 | 7216 | 7260 | 7937 | 7491 | 7568 |
Total Inventory | 6896 | 6818 | 7477 | 7994 | 8352 | 8715 |
Prepaid Expenses | 333 | 469 | 493 | 525 | 615 | |
Other Current Assets, Total | 108 | 2005 | 164 | 188 | 58 | 295 |
Total Assets | 104679 | 99813 | 111408 | 112630 | 114413 | 120242 |
Property/Plant/Equipment, Total - Net | 10019 | 9579 | 9651 | 11017 | 10563 | 11976 |
Property/Plant/Equipment, Total - Gross | 21877 | 22697 | 25151 | 24880 | 27555 | |
Accumulated Depreciation, Total | -11858 | -13046 | -14134 | -14317 | -15579 | |
Goodwill, Net | 40287 | 40264 | 44235 | 44519 | 44364 | 48056 |
Intangibles, Net | 10879 | 13080 | 21889 | 16509 | 18341 | 21407 |
Long Term Investments | 4906 | 5428 | 5550 | 5303 | 2129 | 2425 |
Note Receivable - Long Term | 776 | 730 | 746 | 521 | 537 | 485 |
Other Long Term Assets, Total | 11121 | 4378 | 4758 | 6150 | 4776 | 5329 |
Total Current Liabilities | 16443 | 15463 | 17376 | 20381 | 19248 | 21295 |
Accounts Payable | 4297 | 4633 | 5041 | 5313 | 5295 | 6180 |
Accrued Expenses | 1967 | 1989 | 1978 | 2042 | 2126 | |
Notes Payable/Short Term Debt | 203 | 237 | 249 | 305 | 285 | 189 |
Current Port. of LT Debt/Capital Leases | 1561 | 1038 | 2364 | 4508 | 2714 | 3263 |
Other Current Liabilities, Total | 8415 | 9555 | 7733 | 8277 | 8912 | 9537 |
Total Liabilities | 47127 | 41743 | 52532 | 53574 | 51307 | 51561 |
Total Long Term Debt | 16765 | 14309 | 22071 | 21168 | 20725 | 19015 |
Long Term Debt | 16731 | 14289 | 22053 | 20181 | 19794 | 17176 |
Capital Lease Obligations | 34 | 20 | 18 | 987 | 931 | 1839 |
Deferred Income Tax | 2292 | 1605 | 3414 | 2294 | 1770 | 1617 |
Minority Interest | 170 | 169 | 159 | 174 | 146 | 350 |
Other Liabilities, Total | 11457 | 10197 | 9512 | 9557 | 9418 | 9284 |
Total Equity | 57552 | 58070 | 58876 | 59056 | 63106 | 68681 |
Common Stock | 2584 | 2508 | 2495 | 2508 | 2518 | 2527 |
Additional Paid-In Capital | 51475 | 52862 | 53106 | 52049 | 60511 | 63545 |
Treasury Stock - Common | -1503 | -14 | -153 | -9 | -705 | -939 |
Other Equity, Total | 4996 | 2714 | 3428 | 4508 | 782 | 3548 |
Total Liabilities & Shareholders’ Equity | 104679 | 99813 | 111408 | 112630 | 114413 | 120242 |
Total Common Shares Outstanding | 1271.94 | 1253.85 | 1245.45 | 1253.83 | 1250.69 | 1252.54 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 29502 | 30564 | |||
现金和短期投资 | 9722 | 10098 | |||
现金等价物 | 9722 | 10098 | |||
应收账款总额,净额 | 7425 | 8180 | |||
Accounts Receivable - Trade, Net | 6802 | 7568 | |||
Total Inventory | 9261 | 8715 | |||
Other Current Assets, Total | 3094 | 3571 | |||
Total Assets | 112321 | 120242 | |||
Property/Plant/Equipment, Total - Net | 10976 | 11976 | |||
Goodwill, Net | 44979 | 48056 | |||
Intangibles, Net | 19466 | 21407 | |||
Long Term Investments | 2149 | 2425 | |||
Note Receivable - Long Term | 508 | 485 | |||
Other Long Term Assets, Total | 4741 | 5329 | |||
Total Current Liabilities | 19127 | 21295 | |||
Accounts Payable | 5374 | 6180 | |||
Notes Payable/Short Term Debt | 152 | 189 | |||
Current Port. of LT Debt/Capital Leases | 2320 | 3263 | |||
Other Current Liabilities, Total | 11281 | 11663 | |||
Total Liabilities | 49084 | 51561 | |||
Total Long Term Debt | 19226 | 19015 | |||
Long Term Debt | 17984 | 17176 | |||
Capital Lease Obligations | 1242 | 1839 | |||
Deferred Income Tax | 1674 | 1617 | |||
Minority Interest | 127 | 350 | |||
Other Liabilities, Total | 8930 | 9284 | |||
Total Equity | 63237 | 68681 | |||
Common Stock | 2522 | 2527 | |||
Additional Paid-In Capital | 362 | 63545 | |||
Retained Earnings (Accumulated Deficit) | 59046 | ||||
Treasury Stock - Common | -697 | -939 | |||
Other Equity, Total | 2004 | 3548 | |||
Total Liabilities & Shareholders’ Equity | 112321 | 120242 | |||
Total Common Shares Outstanding | 1252.54 | 1252.54 |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
净收入/起跑线 | 4709 | 8416 | 4306 | 2754 | 12294 | 6223 |
经营活动产生的现金 | 7853 | 7379 | 5547 | 7715 | 7418 | 10522 |
经营活动产生的现金 | 3301 | 3686 | 4279 | 7445 | 3671 | 3351 |
Deferred Taxes | -542 | -909 | -727 | -1772 | -221 | -356 |
非现金物品 | -112 | -3961 | -1031 | -293 | -8001 | -105 |
Cash Taxes Paid | 2096 | 1734 | 2058 | 1695 | 2051 | 1280 |
已付现金利息 | 401 | 347 | 412 | 379 | 315 | 334 |
营运资金的变化 | 497 | 147 | -1280 | -419 | -325 | 1409 |
投资活动产生的现金 | -2637 | 639 | -12872 | -1029 | 3619 | -7298 |
资本支出 | -2083 | -1956 | -1977 | -1787 | -2083 | -2043 |
其他投资现金流量项目,总计 | -554 | 2595 | -10895 | 758 | 5702 | -5255 |
融资活动产生的现金 | -3990 | -7902 | 3934 | -4193 | -6485 | -7056 |
融资现金流项目 | 79 | -52 | -91 | -21 | -44 | -48 |
Total Cash Dividends Paid | -3759 | -3710 | -3773 | -3834 | -3937 | -4008 |
股票的发行(报废),净额 | -2603 | -1843 | -924 | 153 | -619 | -196 |
债务的发行(退还),净额 | 2293 | -2297 | 8722 | -491 | -1885 | -2804 |
外汇效应 | -101 | -74 | 1 | 9 | -64 | 15 |
现金净变化 | 1125 | 42 | -3390 | 2502 | 4488 | -3817 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 2776 | 6223 | |||
Cash From Operating Activities | 4754 | 10522 | |||
Cash From Operating Activities | 1726 | 3351 | |||
Deferred Taxes | -134 | -356 | |||
Non-Cash Items | -149 | -105 | |||
Cash Taxes Paid | 220 | 1280 | |||
Cash Interest Paid | 180 | 334 | |||
Changes in Working Capital | 535 | 1409 | |||
Cash From Investing Activities | -2339 | -7298 | |||
Capital Expenditures | -1018 | -2043 | |||
Other Investing Cash Flow Items, Total | -1321 | -5255 | |||
Cash From Financing Activities | -6616 | -7056 | |||
Financing Cash Flow Items | -41 | -48 | |||
Total Cash Dividends Paid | -4008 | -4008 | |||
Issuance (Retirement) of Stock, Net | -117 | -196 | |||
Issuance (Retirement) of Debt, Net | -2450 | -2804 | |||
Foreign Exchange Effects | 8 | 15 | |||
Net Change in Cash | -4193 | -3817 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
L'Oreal SA | Corporation | 9.3769 | 118227307 | 0 | 2022-01-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 7.3618 | 92820373 | -109952 | 2022-12-01 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 5.032 | 63444721 | 703109 | 2022-10-10 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.5834 | 32572709 | 74521 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.1068 | 26563280 | 1278355 | 2022-12-31 | LOW |
Sanofi SA Employees | Corporation | 1.8586 | 23433679 | -566855 | 2022-01-31 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 1.6609 | 20941703 | 182699 | 2022-12-31 | HIGH |
T. Rowe Price Associates, Inc. | Investment Advisor | 1.3756 | 17344626 | -233 | 2022-12-01 | LOW |
Fidelity International | Investment Advisor | 1.0165 | 12816070 | 7228 | 2022-12-31 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.9217 | 11620994 | 33830 | 2022-12-31 | LOW |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 0.8705 | 10976049 | 9625458 | 2022-11-30 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.8122 | 10240514 | -115847 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.667 | 8409239 | 4 | 2023-01-31 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 0.6576 | 8291246 | -485613 | 2022-12-31 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.5622 | 7088532 | -13850 | 2022-12-31 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.5523 | 6964128 | 59807 | 2022-12-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.5327 | 6716234 | -321183 | 2022-12-31 | LOW |
First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5248 | 6616420 | -237452 | 2022-12-31 | LOW |
BNP Paribas Asset Management France SAS | Investment Advisor/Hedge Fund | 0.5136 | 6475740 | -375463 | 2022-12-31 | LOW |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.4688 | 5910243 | 6677 | 2022-12-31 | LOW |
为什么选择 Capital.com?让我们的数字来说话。
Capital.com Group交易計算器
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
貿易佣金
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
杠杆
20:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Sanofi Company profile
关于 Sanofi SA
赛诺菲公司是一家总部设在法国的医疗保健公司。 公司专注于病人的需求,从事治疗方案的研究、开发、制造和营销。 它的三个运营部门是。 医药、消费者保健(CHC)和疫苗。 制药部门包括。 免疫学、多发性硬化症/神经学、肿瘤学、罕见疾病、罕见血液病、心血管病、糖尿病、成熟的处方药产品。 疫苗业务包括所有地区的赛诺菲巴斯德公司的商业运作,以及专门用于疫苗的研究、开发和生产活动。 CHC业务包括赛诺菲消费者保健产品的商业运作,以及专门用于这些产品的研究、开发和生产活动。 公司合作开发或特许经营的产品包括Dupixent、Aubagio、Lemtrada、Cerezyme、Lumizyme、Jevtana、Fabrazyme,等等。
Industry: | Pharmaceuticals (NEC) |
54 Rue la Boétie
PARIS
ILE-DE-FRANCE 75008
FR
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。